FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info |

Start Over | Back to Search Results

Sodium Chloride 0.9% Injection Bags
Status: Currently in Shortage
»Date first posted: 01/15/2014
»Therapeutic Categories: Gastroenterology; Other; Pediatric

For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Health-System Pharmacists.
Small-Volume Parenteral Solutions Shortages, Suggestions for Management and Conservation

Expand all

B. Braun Medical Inc. (Revised 01/11/2018)

Company Contact Information:
800-227-2862

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.9% NaCl 250mL bag, PVC/DEHP-free (NDC 00264-7800-20)	Product on allocation, estimated recovery Q1 2018	BBraun Customer Letter IV Solution Shortage	Manufacturing interruptions and demand increase
0.9% NaCl 500mL bag, PVC/DEHP-free (NDC 00264-7800-10)	Product on allocation, estimated recovery Q1 2018	BBraun Customer Letter IV Solution Shortage	Manufacturing interruptions and demand increase
0.9% NaCl 1000mL bag, PVC/DEHP-free (NDC 00264-7800-00)	Product on allocation, estimated recovery Q1 2018	BBraun Customer Letter IV Solution Shortage	Manufacturing interruptions and demand increase
0.9% Sodium Chloride Injection USP 100mL fill in 150mL PAB S8004-5264 (NDC 0264-1800-32)	Product on allocation. Estimated recovery: Q1 2018	BBraun Customer Letter IV Solution Shortage	Manufacturing interruptions and demand increase
0.9% Sodium Chloride Injection USP 50mL fill in 100mL PAB S8004-5384 (NDC 0264-1800-31)	Product on allocation. Estimated recovery: Q1 2018	BBraun Customer Letter IV Solution Shortage	Manufacturing interruptions and demand increase
0.9% Sodium Chloride Injection USP 25mL fill in 100mL PAB S8004-5410 (NDC 0264-1800-36)	Product on allocation. Estimated recovery: Q1 2018	BBraun Customer Letter IV Solution Shortage	Manufacturing interruptions and demand increase
Sodium Chloride 0.9% w/v Intravenous Infusion BP in the Ecoflac® plus 1,000 mL Product Code 9999-00, (NDC 0264-9999-00)	Availability estimated in February 2018	Dear Health Care Provider Letter Useful Handling Tips for Ecloflac plus Useful Handling Tips for Ecloflac plus - Infusion Administration	Available
Sodium Chloride 0.9% w/v Intravenous Infusion BP in the Ecoflac® plus container sizes: 500 mL (NDC 0264-9999-10)	Available	B. Braun Medical Inc. in conjunction with FDA has initiated temporary importation of Sodium Chloride 0.9% w/v Intravenous Infusion BP in the Ecoflac® plus container into the U.S. market to address drug shortage. Importation will begin mid October 2014. Limited quantities available from B. Braun or authorized distributors. All orders must be placed with B. Braun Medical Inc Customer Service at 1-800-227-2862. Please see Dear Health Care Provider Letter (PDF). Dear Health Care Provider Letter Useful Handling Tips for Ecloflac plus Useful Handling Tips for Ecloflac plus - Infusion Administration	Available

Baxter Healthcare (Revised 04/16/2018)

Company Contact Information:
888-229-0001

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.9% Sodium Chloride Injection, 100 mL, in VIAFLEX Container. Product code FZB1307 (NDC 0338-9517-72)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Sodium Chloride 0.9% Injection in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Letter, Brazil	Other
0.9% Sodium Chloride Injection, 250 mL, in VIAFLEX Container. Product code FZB1322 (NDC 0338-9517-50)	Limited quantities will be available in March. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Sodium Chloride 0.9% Injection in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Letter, Brazil	Other
0.9% Sodium Chloride Injection, 500 mL, in VIAFLEX Container. Product code FZB1323 (NDC 0338-9517-30)	Limited quantities will be available in March. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Sodium Chloride 0.9% Injection in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Letter, Brazil	Other
0.9% Sodium Chloride Injection, 1,000 mL, in VIAFLEX Container. Product code FZB1324 (NDC 0338-9517-16)	Limited quantities will be available in March. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Sodium Chloride 0.9% Injection in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Letter, Brazil	Other
0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Plastic Container. Single pack (NDC 0338-0049-48) Quad Pack (NDC 0338-0049-18) Multi Pack (NDC 0338-0049-38)	On allocation		Other
0.9% Sodium Chloride Injection, USP, 50 mL VIAFLEX Plastic Container. Single Pack (NDC 0338-0049-41) Quad Pack (NDC 0338-0049-11) Multi Pack (NDC 0338-0049-31)	On allocation		Other
0.9% Sodium Chloride Injection, USP, 25 mL VIAFLEX Plastic Container Quad Pack (NDC 0338-0049-10)	On allocation		Other
Sodium Chloride 0.9% Intravenous Infusion, 100 mL, in VIAFLEX Container Product code AHB1307 (NDC 0338-9563-48)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Sodium Chloride 0.9% Intravenous Infusion in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Provider Letter, Australia	Other
Sodium Chloride 0.9% Intravenous Infusion, 50 mL, in VIAFLEX Container Product code AHB1306A (NDC 0338-9567-60)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Sodium Chloride 0.9% Intravenous Infusion in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Provider Letter, Australia	Other
Sodium Chloride 0.9% w/v Intravenous Infusion, BP, 50 mL, MINI-BAG Plus container, VIAFLEX plastic container Product code FPB0042G (NDC 0338-9613-30)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Sodium Chloride 0.9% w/v Intravenous Infusion BP in MINI-BAG Plus container in VIAFLEX (PVC) plastic container into the U.S. market to address drug shortages. Dear Health Care Provider Letter, Ireland	Other
0.9% Sodium Chloride Injection, USP, 50 mL MINI-BAG Plus Container, VIAFLEX Plastic Container (NDC 0338-0553-11)	On allocation		Other
Sodium Chloride 0.9% w/v Intravenous Infusion, BP, 100 mL, MINI-BAG Plus in VIAFLEX plastic container, Product code FPB0043G (NDC 0338-9616-30)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Sodium Chloride 0.9% w/v Intravenous Infusion BP in MINI-BAG Plus container in VIAFLEX (PVC) plastic container into the U.S. market to address drug shortages. Dear Health Care Letter, Ireland	Other
0.9% Sodium Chloride Injection, USP, 100 mL MINI-BAG Plus Container, VIAFLEX Plastic Container (NDC 0338-0553-18)	On allocation		Other
0.9% Sodium Chloride in Water for Injection, 50 mL, in VIAFLEX Container Product code ABB1306U (NDC 0338-9520-11)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 0.9% Sodium Chloride in Water for Injection in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Letter, Mexico	Other
0.9% Sodium Chloride in Waiter for Injection, 100 mL, in VIAFLEX Container Product code ABB1307U (NDC 0338-9525-72)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 0.9% Sodium Chloride Injection in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Letter, Mexico	Other
0.9% Sodium Chloride Injection, USP, 50 mL, in VIAFLEX Container Product code JB1301P (NDC 0338-9579-96)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 0.9% Sodium Chloride Injection, USP, in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Letter, Canada	Other
0.9% Sodium Chloride Injection, USP, 100 mL, in VIAFLEX Container Product code JB1302P (NDC 0338-9583-96)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 0.9% Sodium Chloride Injection, USP, in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Letter, Canada	Other
0.9% Sodium Chloride Injection, USP, 50 mL, in MINI-BAG Plus Container, Product code JB0042 (NDC 0338-9531-96)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 0.9% Sodium Chloride Injection USP in MINI-BAG Plus container, VIAFLEX (PVC) plastic container into the U.S. market to address drug shortages. Dear Health Care Letter, Canada	Other
0.9% Sodium Chloride Injection, USP, 100 mL, in MINI-BAG Plus Container, VIAFLEX Plastic Container. Product code JB0043P (NDC 0338-9535-72)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 0.9% Sodium Chloride Injection, USP, MINI-BAG Plus Container, VIAFLEX plastic container into the U.S. market to address drug shortages. Dear Health Care Letter, Canada	Other
0.9% Sodium Chloride Injection, USP, 250 mL. Product code JB1322P (NDC 00338-9604-30)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 0.9% Sodium Chloride Injection, USP, in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Letter, Canada	Other
0.9% Sodium Chloride Injection, USP, 500 mL. Product code JB1323 (NDC 00338-9608-24)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 0.9% Sodium Chloride Injection, USP, in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Letter, Canada	Other
0.9% Sodium Chloride Injection, USP, 1000 mL. Product code JB1324 (NDC 00338-9612-12)	Limited quantities will be available in the next few weeks. Baxter will provide further updates as more product becomes available.	Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of 0.9% Sodium Chloride Injection, USP, in VIAFLEX Container into the U.S. market to address drug shortages. Dear Health Care Letter, Canada	Other

Fresenius Kabi USA, LLC (Revised 04/03/2018)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Shortage Reason (per FDASIA)
Sodium Chloride Injection USP, 0.9%, 50mL (NDC 63323-623-53)	Limited quantity release anticipated March 2018.	Increase in demand
Sodium Chloride Injection USP, 0.9%, 100mL (NDC 63323-623-61)	Limited inventory available.	Increase in demand
Sodium Chloride Injection USP, 0.9%, 250mL (NDC 63323-623-74)	Release anticipated mid Q2 - 2018.	Increase in demand
Sodium Chloride Injection USP, 0.9%, 500mL (NDC 63323-623-75)	Limited inventory available.	Increase in demand
Sodium Chloride Injection USP, 0.9%, 1000mL (NDC 63323-623-76)	Limited inventory available.	Increase in demand

Fresenius Medical Care North America (Revised 10/27/2017)

Company Contact Information:
800-323-5188

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
1000ml (NDC 49230-300-10)	Fresenius has this product on allocation		Demand increase for the drug

Hospira, Inc. (Revised 04/13/2018)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Shortage Reason (per FDASIA)
0.9%; 50 mL (5-Pack) ADD-Vantage™ Flexible Container (NDC 0409-7101-66)	Limited supply available. Next delivery: Mid April 2018; Estimated recovery: March 2019	Demand increase for the drug
0.9%; 100 mL (5-Pack) ADD-Vantage™ Flexible Container (NDC 0409-7101-67)	Limited supply available. Next delivery: Late April 2018; Estimated recovery: March 2019	Demand increase for the drug
0.9%; 250 mL (Dual Pack) ADD-Vantage™ Flexible Container (NDC 0409-7101-02)	Limited Supply Available. Next delivery: Mid April 2018; Estimated recovery: June 2018	Demand increase for the drug

ICU Medical, Inc. (Revised 04/17/2018)

Company Contact Information:
877-946-7747

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
50 mL flexible container (NDC 0409-7984-13)	Next delivery: Early June Estimated recovery: Early June	Please check with your wholesaler for available inventory. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.	Demand increase for the drug
100 mL flexible container (NDC 0409-7984-23)	Next delivery and estimated recovery: Mid May	Please check with your wholesaler for available inventory. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.	Demand increase for the drug
100 mL flexible container-4 pack (NDC 0409-7984-37)	Next delivery and estimated recovery: Mid June	Please check with your wholesaler for available inventory. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.	Demand increase for the drug
150mL flexible container (NDC 0409-7983-61)	Available	Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.	Other
250mL Vis-IV container, PVC/DEHP-free (NDC 0409-7983-25)	Next delivery: Mid May Estimated recovery: Early June	Please check with your wholesaler for available inventory. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.	Demand increase for the drug
250mL flexible container (NDC 0409-7983-02)	Available	Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.	Other
250mL flexible container 2 port (NDC 0409-7983-53)	Available	Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.	Other
500mL flexible container 2 port (NDC 0409-7983-55)	Available	Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.	Other
500mL flexible container (NDC 0409-7983-03)	Available	Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.	Other
1000mL flexible container (NDC 0409-7983-09)	Available	Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.	Other

Laboratorios Grifols, S.A. (Revised 03/01/2018)

Company Contact Information:
800-848-0462

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.9% Sodium Chloride Injection, USP 500 mL Fleboflex Plastic Container (20 units/carton)(NDC NDC 76297-001-01)	Estimated availability: March 2018	Manufacturer: Laboratorios Grifols, S.A.; Distributor: Henry Schein 1-866-248-9907 Dear Customer Letter	Other